The effect of Riociguat on cardiovascular function and efficiency in healthy, juvenile pigs

INTRODUCTION: Riociguat is a soluble guanylate cyclase stimulator approved for the treatment of pulmonary hypertension. Its effect on cardiometabolic efficiency is unknown. A potential cardiac energy sparing effect of this drug could imply a positive prognostic effect, particularly in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Næsheim, Torvind, How, Ole‐Jakob, Myrmel, Truls
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507463/
https://www.ncbi.nlm.nih.gov/pubmed/32918535
http://dx.doi.org/10.14814/phy2.14562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507463/
https://www.ncbi.nlm.nih.gov/pubmed/32918535
http://dx.doi.org/10.14814/phy2.14562

Ejemplares similares